Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lübbert

Showing results (71-80 of 119) with videos related to

Pageof 12
Sort By:
Leukemia Research|September 21, 2007
Efficacy of decitabine in the treatment of patients with chronic myelomonocytic leukemia (CMML)P W Wijermans, B Rüter, M R Baer, et al.
Leukemia|February 22, 2013
A novel recurrent AML1-ETO fusion: tight in vivo association with BCR-ABL1L Solari, T Bauer, F Dicker, et al.
Blood|July 1, 1989
Novel vitamin D analogs that modulate leukemic cell growth and differentiation with little effect on either intestinal calcium absorption or bone mobilizationJ Y Zhou, A W Norman, M Lübbert, et al.
Blood|May 15, 1990
Inducible production of interleukin-6 by human polymorphonuclear neutrophils: role of granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alphaN A Cicco, A Lindemann, J Content, et al.
FEBS Letters|September 17, 1990
Differential regulation of interleukin-6 expression in human fibroblasts by tumor necrosis factor-alpha and lymphotoxinL Mantovani, R Henschler, M A Brach, et al.
Leukemia|April 7, 2006
Inducible expression of AML1-ETO fusion protein endows leukemic cells with susceptibility to extrinsic and intrinsic apoptosisY Lu, Y-B Xu, T-T Yuan, et al.
Annals of Hematology|September 12, 2008
Determination of Ras-GTP and Ras-GDP in patients with acute myelogenous leukemia (AML), myeloproliferative syndrome (MPS), juvenile myelomonocytic leukemia (JMML), acute lymphocytic leukemia (ALL), and malignant lymphoma: assessment of mutational and indirect activationD Raepple, F von Lintig, T Zemojtel, et al.
Leukemia|February 6, 2009
The DNA methyltransferase inhibitors azacitidine, decitabine and zebularine exert differential effects on cancer gene expression in acute myeloid leukemia cellsC Flotho, R Claus, C Batz, et al.
Leukemia Research|February 9, 2006
Trisomy 19 as the sole chromosomal abnormality in proliferative chronic myelomonocytic leukemiaM Daskalakis, N Mauritzson, B Johansson, et al.
Leukemia|September 27, 2003
Efficacy and safety of imatinib mesylate (Glivec) in combination with interferon-alpha (IFN-alpha) in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL)B Wassmann, U Scheuring, H Pfeifer, et al.
Pageof 12

Showing results (71-80 of 119) with videos related to

Sort By:
Pageof 12
Leukemia Research|September 21, 2007
Efficacy of decitabine in the treatment of patients with chronic myelomonocytic leukemia (CMML)P W Wijermans, B Rüter, M R Baer, et al.
Leukemia|February 22, 2013
A novel recurrent AML1-ETO fusion: tight in vivo association with BCR-ABL1L Solari, T Bauer, F Dicker, et al.
Blood|July 1, 1989
Novel vitamin D analogs that modulate leukemic cell growth and differentiation with little effect on either intestinal calcium absorption or bone mobilizationJ Y Zhou, A W Norman, M Lübbert, et al.
Blood|May 15, 1990
Inducible production of interleukin-6 by human polymorphonuclear neutrophils: role of granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alphaN A Cicco, A Lindemann, J Content, et al.
FEBS Letters|September 17, 1990
Differential regulation of interleukin-6 expression in human fibroblasts by tumor necrosis factor-alpha and lymphotoxinL Mantovani, R Henschler, M A Brach, et al.
Leukemia|April 7, 2006
Inducible expression of AML1-ETO fusion protein endows leukemic cells with susceptibility to extrinsic and intrinsic apoptosisY Lu, Y-B Xu, T-T Yuan, et al.
Annals of Hematology|September 12, 2008
Determination of Ras-GTP and Ras-GDP in patients with acute myelogenous leukemia (AML), myeloproliferative syndrome (MPS), juvenile myelomonocytic leukemia (JMML), acute lymphocytic leukemia (ALL), and malignant lymphoma: assessment of mutational and indirect activationD Raepple, F von Lintig, T Zemojtel, et al.
Leukemia|February 6, 2009
The DNA methyltransferase inhibitors azacitidine, decitabine and zebularine exert differential effects on cancer gene expression in acute myeloid leukemia cellsC Flotho, R Claus, C Batz, et al.
Leukemia Research|February 9, 2006
Trisomy 19 as the sole chromosomal abnormality in proliferative chronic myelomonocytic leukemiaM Daskalakis, N Mauritzson, B Johansson, et al.
Leukemia|September 27, 2003
Efficacy and safety of imatinib mesylate (Glivec) in combination with interferon-alpha (IFN-alpha) in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL)B Wassmann, U Scheuring, H Pfeifer, et al.
Pageof 12